|
| |
BioPortfolio's Approved Drugs DatabaseTaclonexBeta Methasone Dipropionate Calcipotriene HydrateDownload PDF containing detailed information.
Press Releases About Taclonex:
|
 |
| Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists |
28th May, 2009 |
BioTrends Research Group, Inc. |
EXTON, Pa., May 28 /PRNewswire/ -- BioTrends Research Group today released its syndicated report TreatmentTrends(R): Psoriasis, the fourth annual survey of U.S. Dermatologists (n=150). The report,
|
| Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis |
5th June, 2008 |
BioTrends Research Group, Inc. |
EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc. released
its third annual TreatmentTrends (TM): Psoriasis publication, providing
insight into the management of psoriasis. This
|
Companies working in the area of Taclonex from Bioportfolio's Biocorporate database : |  |
| Company Name | |
Warner Chilcott is a leading specialty pharmaceutical company focused on developing, manufacturing and marketing and selling branded prescription pharmaceutical products in women’s healthcare and...
www.warnerchilcott.com/ View full profile
| |
This page has been viewed 19 times
Browse BioPortfolio's InDepth service - alphabetically:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
or by Most Publications, recently searched for, or
most viewed.
Search for Taclonex across BioPortfolio, or for Taclonex Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH.
Thumbshots from Thumbshots.org
|